Tesamorelin 5mg

Tesamorelin 5mg belongs to a class of premium synthetic peptide compounds, engineered as a potent analog of human growth hormone-releasing hormone (GHRH) exclusively developed for academic laboratory testing, biomedical investigation and preclinical research purposes, and it is not intended for human clinical administration. This bioactive peptide is manufactured with strict purification protocols to guarantee high molecular purity, stable structural integrity and consistent biological activity across all batches.

To satisfy diverse experimental design requirements and varying dosage demands of research teams, we supply Tesamorelin in four standardized lyophilized powder specifications: 2mg, 5mg, 10mg and 20mg per sterile vial. The lyophilization process effectively eliminates moisture-induced degradation, locking in the peptide's bioactivity during long-term storage and cross-regional transportation. Each vial undergoes aseptic filling, vacuum sealing and comprehensive quality inspection, minimizing contamination risks. Researchers can flexibly select the matching specification based on cell culture trials, animal model studies and endocrinology-related projects, delivering dependable, reproducible experimental data for growth hormone pathway analysis and related peptide mechanism exploration.